GlassScriptPhysician profile
Zachary Tan
NPI 1013438779
$17,455.98
in general payments reported to CMS, 2019-2025
38 companies · $1,178 in 2025
The $1,178 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,455 · 2020: $3,377 · 2022: $1,399 · 2023: $1,649 · 2024: $5,397 · 2025: $1,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,243 · Food and Beverage: $3,982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,242.89 |
| Food and Beverage | $3,981.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,082.91 | 2019-2025 | Mako, Tornier Perform Anatomic Augmented Glenoid, Variax |
| Globus Medical, INC. | $3,022.06 | 2019-2022 | |
| Spine Wave, INC. | $1,303.92 | 2019-2020 | |
| Medtronic USA, INC. | $1,145.16 | 2019-2020 | |
| Linvatec Corporation | $1,007.59 | 2023-2024 | Biobrace 23mm, Livatec Knee Preservation System, Linvatec Shoulder Arthroscopy |
| Life Spine, INC. | $965.32 | 2019-2020 | |
| Relievant Medsystems, INC. | $775.81 | 2019-2020 | |
| Microport Orthopedics INC | $625.83 | 2024 | Mpo Medial Pivot Knee, Mpo Hip System |
| Camber Spine Technologies LLC | $430.44 | 2020 | |
| Medtronic, INC. | $375.51 | 2022-2023 | Kyphon Express II Kyphopak Tray |
| Si-Bone, INC. | $306.69 | 2019-2020 | |
| Exactech, INC. | $159.94 | 2019 | |
| Amgen INC. | $159.50 | 2019-2023 | Prolia, Evenity |
| Invictus Surgical Incorporated | $139.85 | 2024 | |
| Mimedx Group, INC. | $125.40 | 2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $113.42 | 2019-2020 | |
| Depuy Synthes Sales INC. | $78.70 | 2019 | |
| 7d Surgical INC. | $70.91 | 2019 | |
| Heron Therapeutics, INC. | $51.56 | 2023-2024 | Zynrelef |
| Takeda Pharmaceuticals U.S.A., INC. | $50.13 | 2024-2025 | Entyvio |
| Sanara Medtech INC. | $43.36 | 2024 | Celleraterx |
| Innovation Technologies INC | $42.16 | 2022 | |
| Electronic Waveform Lab, INC. | $35.83 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.59 | 2025 | |
| Boston Scientific Corporation | $35.12 | 2022 | |
| Avanos Medical | $31.47 | 2024 | Generator |
| Abbott Laboratories | $28.57 | 2019 | |
| Recordati_rare_diseases_inc. | $26.04 | 2025 | Isturisa |
| Kyowa Kirin, INC. | $24.59 | 2025 | |
| Innovasis INC | $23.59 | 2022 | |
| Nevro Corp. | $23.00 | 2022 | |
| Zimvie INC. | $19.93 | 2022 | |
| Corcept Therapeutics | $19.65 | 2025 | Korlym |
| Abbvie INC. | $19.11 | 2023 | Ubrelvy |
| Allergan, INC. | $16.06 | 2019 | |
| Glaxosmithkline, LLC. | $15.68 | 2025 | Penmenvy, Bexsero, Rotarix |
| Misonix INC | $14.65 | 2020 | |
| Horizon Therapeutics Plc | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.